Cohero Health Aims To Improve Patient Care For The 26 Million American Asthma … – TechCrunch


TechCrunch

Cohero Health Aims To Improve Patient Care For The 26 Million American Asthma
TechCrunch
Cohero Health, a startup that aims to improve care and medicine adherence for people with respiratory issues just debuted its comprehensive connected health platform for asthma patients on stage at TechCrunch Disrupt San Francisco 2015. Starting today …

View full post on asthma – Google News

Patient identification, coordinator implementation improve childhood asthma … – Healio

Patient identification, coordinator implementation improve childhood asthma
Healio
An analysis of four research sites coordinating care for children with asthma showed that the unique solutions for identifying participants in the program, as well as how the sites implemented asthma care coordinators into the clinical pathway

and more »

View full post on asthma – Google News

Glaxo Asthma Drug Stumbles in Ambitious Heart Patient Study – Bloomberg


The Express Tribune

Glaxo Asthma Drug Stumbles in Ambitious Heart Patient Study
Bloomberg
GlaxoSmithKline Plc's Breo Ellipta medicine didn't extend lives in an ambitious study that sought to show the drug could help patients suffering from both lung and heart troubles. Patients taking the inhaled asthma drug Breo were 12 percent less likely
GSK inhaler trial fails to show longer lifeMarketWatch
Respiratory drug trial failure deals blow to GSK revival planFinancial Times
GSK and Theravance Announce Results From the SUMMIT COPD CV Survival StudyCNNMoney
StreetInsider.com –Medical Xpress
all 60 news articles »

View full post on asthma – Google News

When Cortricosteroid Use Can Be Life-Threatening for an Asthma Patient – Monthly Prescribing Reference (registration)


Monthly Prescribing Reference (registration)

When Cortricosteroid Use Can Be Life-Threatening for an Asthma Patient
Monthly Prescribing Reference (registration)
Clinicians should exercise caution when prescribing steroids in patients presenting with an exacerbation of asthma in areas endemic for Strongyloides stercoralis (SS), as a patient experienced hyperinfection syndrome from prednisone treatment at the

View full post on asthma – Google News

Asthma app study data on ResearchKit shows mixed results for patient … – MedCity News


MedCity News

Asthma app study data on ResearchKit shows mixed results for patient
MedCity News
The company, a spin-off of LifeMap Sciences, noted that preliminary data for Asthma Health showed that more than half of users “not only complete the e-consent process, they also come back the very next day to use the app. This is a very high rate of

and more »

View full post on asthma – Google News

Study: Twitter Could Help Predict Asthma-Related ED Patient Volume – iHealthBeat


Lauderdale Daily News

Study: Twitter Could Help Predict Asthma-Related ED Patient Volume
iHealthBeat
The researchers found no meaningful relationship between the asthma-related Google searches and ED visits (Budryk, FierceHealthcare, 4/16). The authors noted that they are working to expand their research to see if their preliminary findings hold when …
How Twitter Can Help Predict Emergency Room VisitsScientific Computing
Twitter can help predict emergency room visitsZee News

all 40 news articles »

View full post on asthma – Google News

Desensitization to ceftaroline in a patient with multiple medication hypersensitivity reactions.

Related Articles

Desensitization to ceftaroline in a patient with multiple medication hypersensitivity reactions.

Am J Health Syst Pharm. 2015 Feb 1;72(3):198-202

Authors: Jones JM, Richter LM, Alonto A, Leedahl DD

Abstract
PURPOSE: The case of a patient with multiple medication hypersensitivity reactions and a methicillin-resistant Staphylococcus aureus (MRSA) infection who underwent desensitization to ceftaroline is reported.
SUMMARY: A 32-year-old Caucasian woman with asthma, gastroesophageal reflux disease, heart murmur, and major depression was admitted for MRSA cellulitis with a subcutaneous abscess along the left sternomanubrial joint and clavicular osteomyelitis secondary to port placement after gastric bypass surgery. The patient had an extensive history of hypersensitivity reactions. Pertinent documented allergies were as follows: penicillin (anaphylaxis), daptomycin (anaphylaxis), vancomycin (hives), linezolid (hives), ertapenem (rash), ciprofloxacin (rash), and tigecycline (rash). The patient also reported previous reactions to aztreonam (unknown) and gentamicin (hives). The pharmacy was consulted to develop a desensitization protocol for ceftaroline. The desensitization protocol used three serial dilutions of ceftaroline to make 14 sequential infusions with escalating doses. Intramuscular epinephrine, i.v. diphenhydramine, and i.v. methylprednisolone were ordered as needed for the development of immediate hypersensitivity reactions during or after administration of ceftaroline. The cumulative dose (574.94 mg) was administered intravenously over 225 minutes with no breakthrough symptoms reported during or after the desensitization protocol. Ceftaroline fosamil 600 mg i.v. every 12 hours was continued for six weeks.
CONCLUSION: Desensitization to ceftaroline was conducted for a patient with extensive history of hypersensitivity reactions to other drugs, including penicillin-induced anaphylaxis. Desensitization and subsequent treatment with full doses of ceftaroline were accomplished without apparent adverse effects.

PMID: 25596602 [PubMed – in process]

View full post on pubmed: asthma